These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 1332702)

  • 1. A synthetic peptide derived from A1 module in CRD4 of human TNF receptor-1 inhibits binding and proinflammatory effect of human TNF-alpha.
    Cao Y; Wang Z; Bu X; Tang S; Mei Z; Liu P
    Inflammation; 2009 Jun; 32(3):139-45. PubMed ID: 19274442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.
    Teng MN; Collins PL
    J Virol; 2002 Jun; 76(12):6164-71. PubMed ID: 12021350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of immunologically active therapeutic peptides.
    Murali R; Greene MI
    Immunol Res; 1998; 17(1-2):163-9. PubMed ID: 9479578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping protein-protein contact sites using cellulose-bound peptide scans.
    Reineke U; Sabat R; Kramer A; Stigler RD; Seifert M; Michel T; Volk HD; Schneider-Mergener J
    Mol Divers; 1996 May; 1(3):141-8. PubMed ID: 9237205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor necrosis factor in the brain suppresses rabbit sleep.
    Takahashi S; Tooley DD; Kapás L; Fang J; Seyer JM; Krueger JM
    Pflugers Arch; 1995 Dec; 431(2):155-60. PubMed ID: 9026774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts.
    Vilcek J; Tsujimoto M; Palombella VJ; Kohase M; Le J
    J Cell Physiol Suppl; 1987; Suppl 5():57-61. PubMed ID: 2824534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro.
    Hwang CD; Gatanaga M; Innins EK; Yamamoto RS; Granger GA; Gatanaga T
    Proc Biol Sci; 1991 Aug; 245(1313):115-9. PubMed ID: 1682934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
    Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
    Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding.
    Hohmann HP; Remy R; Pöschl B; van Loon AP
    J Biol Chem; 1990 Sep; 265(25):15183-8. PubMed ID: 2168404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
    Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.
    Vandenabeele P; Declercq W; Vercammen D; Van de Craen M; Grooten J; Loetscher H; Brockhaus M; Lesslauer W; Fiers W
    J Exp Med; 1992 Oct; 176(4):1015-24. PubMed ID: 1328463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides.
    Lie BL; Tunemoto D; Hemmi H; Mizukami Y; Fukuda H; Kikuchi H; Kato S; Numao N
    Biochem Biophys Res Commun; 1992 Oct; 188(2):503-9. PubMed ID: 1332702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha: a multifaceted peptide hormone.
    Rosenblum MG; Donato NJ
    Crit Rev Immunol; 1989; 9(1):21-44. PubMed ID: 2539946
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.